All healthcare systems today are under pressure to spend their resources wisely and efficiently. Ever more often the concept of 'value-based healthcare' is discussed as an idea to improve resource allocation. Value-based healthcare (VBHC), a broad term that describes efforts to maximise quality of care and health outcomes relative to expenditures, is an important trend with the potential to reshape the healthcare landscape.
The 'Future of Value-Based Healthcare in Ireland’ webinar series – hosted by RCSI's Healthcare Outcomes Research Centre in association with Janssen Sciences Ireland and Novartis Pharmaceuticals Ireland – aims to facilitate discussion and introduce new perspectives on VBHC. It also examines what this looks like in an Irish context and what value-based health arrangements, such as a greater focus on disease prevention, outcomes and patient centricity, mean for the Irish health services.
Chaired by former Health Service Executive (HSE) Director General, Tony O’Brien, the first webinar looked at what Ireland can learn from other European countries about ‘pay for performance’ models of healthcare to support better population health outcomes and improved patient experience, while at the same time making better use of available healthcare resources or possibly lowering the costs of care.
- Dr Panos Kefalas, Director of Access Strategy, Cell and Gene Therapy, Catapult
- Dr Lesley Tilson, Deputy Head, National Centre for Pharmacoeconomics
- Shane Gannon, Sector Lead, Pharma and Life Science Consulting, PwC Ireland
This webinar focuses on how Ireland can improve on the collection and use of good-quality real-world health data in the context of value-based healthcare. Health systems can learn from our collective data to improve the quality, integration, and safety of care, but by comparison with our European peers, Ireland fares poorly in the collection and sharing of quality data on care and treatment. Chaired by Business Post columnist and former Health Service Executive Director General Tony O’Brien, the webinar examines key challenges, such as how to improve availability and use of better data for policy making and service planning, clinical decision-making and patient care, for clinical trials and research and for measuring cost-effectiveness and value for money.
- Dr Aisling O’Leary, National Centre for Pharmacoeconomics & School of Pharmacy, RCSI
- Dr Conor Teljeur, Chief Scientist, Health Information and Quality Authority
- Dr Thomas Kelley, CEO, Sprink, UK
The third and final webinar of the ‘Future of Value-Based Healthcare in Ireland’ series focuses on how Ireland can create more patient-focused healthcare initiatives in the context of value-based healthcare. Increasingly, it is recognised that patients in Ireland have a key role to play in improving the quality of the health service they receive by participating in the design and delivery of the service themselves. Meaningful consultation with patients can help providers understand the quality of care a patient receives in areas such as the effectiveness of treatments.
This webinar explores how to ensure value-based healthcare initiatives are patient-centred. The panel of experts examines how the Irish health service compares to other countries on the integration of patient experience into clinical care, how we improve the routine collection of Patient Reported Outcome Measures (PROMs) in our health service, and the barriers to the greater integration of patient experience into healthcare and service planning.
- Prof. Frances Horgan, Associate Professor of Physiotherapy, RCSI University of Medicine and Health Sciences
- David Galvin MD FRCS (Urol), Consultant Urologist, Mater and St Vincent’s Hospital, Assistant Professor, University College Dublin
- Anne Lawlor, Founding Member and Chairperson, 22q11 Ireland Support Group
- Derick Mitchell, PhD, Chief Executive Officer, Irish Platform for Patient Organisations, Science & Industry (IPPOSI)